Caroli syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:480520Q44.6
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Caroli syndrome (also known as Caroli disease with congenital hepatic fibrosis) is a rare congenital disorder characterized by segmental, non-obstructive, saccular or fusiform dilatation of the intrahepatic bile ducts combined with congenital hepatic fibrosis. It is distinguished from Caroli disease (simple type), which involves bile duct dilatation alone without hepatic fibrosis. Caroli syndrome primarily affects the hepatobiliary system and is associated with the ductal plate malformation, a developmental abnormality of the intrahepatic bile ducts. It is most commonly linked to autosomal recessive polycystic kidney disease (ARPKD) and mutations in the PKHD1 gene. Key clinical features include recurrent episodes of bacterial cholangitis (infection of the bile ducts), intrahepatic stone formation (hepatolithiasis), and complications of portal hypertension secondary to congenital hepatic fibrosis, such as splenomegaly, esophageal varices, and gastrointestinal bleeding. Patients may also develop renal abnormalities, particularly renal cystic disease consistent with ARPKD. The stagnation of bile within the dilated ducts predisposes to stone formation and recurrent infections, which can lead to sepsis and liver abscesses. There is also a long-term increased risk of cholangiocarcinoma (bile duct cancer). Management of Caroli syndrome is primarily supportive and aimed at preventing and treating complications. This includes antibiotic therapy for cholangitis episodes, ursodeoxycholic acid to improve bile flow, and endoscopic or surgical interventions for stone removal. Portal hypertension complications may require endoscopic variceal management or portosystemic shunting. In severe or progressive cases, liver transplantation remains the only curative treatment option and may be considered especially when recurrent cholangitis is refractory to medical therapy or when cholangiocarcinoma is suspected. Early diagnosis and multidisciplinary follow-up involving hepatologists, surgeons, and nephrologists are essential for optimal patient outcomes.

Clinical phenotype terms— hover any for plain English:

CholangiocarcinomaHP:0030153Conjunctival icterusHP:0032106Liver abscessHP:0100523Abnormal ductus choledochus morphologyHP:0100889Periportal fibrosisHP:0001405Intrahepatic cholestasisHP:0001406Abnormal intrahepatic bile duct morphologyHP:0011040Conjugated hyperbilirubinemiaHP:0002908ChillsHP:0025143CholangitisHP:0030151Abdominal rigidityHP:0032545
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Caroli syndrome.

View clinical trials →

No actively recruiting trials found for Caroli syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Caroli syndrome community →

Specialists

15 foundView all specialists →
RP
Rajniti Prasad
Specialist
1 Caroli syndrome publication
XL
Xiaohu Li
Specialist
1 Caroli syndrome publication
EF
Eslam Kamal Fahmy
Specialist
1 Caroli syndrome publication
RN
Rania Naguib
Specialist
1 Caroli syndrome publication
AO
Ahmed F Omar
Specialist
1 Caroli syndrome publication
HN
Hend Naguib
Specialist
1 Caroli syndrome publication
MA
Mohamed Mahmoud Abdelrahman
Specialist
1 Caroli syndrome publication
AG
Ali Ghassa
Specialist
1 Caroli syndrome publication
LK
Lina Khouri
Specialist
1 Caroli syndrome publication
AA
Aditi Agarwal
KIRKLAND, WA
Specialist
1 Caroli syndrome publication
AS
Ankur Singh
WILMINGTON, NC
Specialist
1 Caroli syndrome publication
AA
Abhishek Abhinay
Specialist
1 Caroli syndrome publication
HE
Hany A Elkattawy
Specialist
1 Caroli syndrome publication
FE
Fabio Caleça Emidio
Specialist
1 Caroli syndrome publication
MA
Moaz Abulfaraj
FORT DEFIANCE, AZ
Specialist
1 Caroli syndrome publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Caroli syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Caroli syndromeForum →

No community posts yet. Be the first to share your experience with Caroli syndrome.

Start the conversation →

Latest news about Caroli syndrome

No recent news articles for Caroli syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Caroli syndrome

What is Caroli syndrome?

Caroli syndrome (also known as Caroli disease with congenital hepatic fibrosis) is a rare congenital disorder characterized by segmental, non-obstructive, saccular or fusiform dilatation of the intrahepatic bile ducts combined with congenital hepatic fibrosis. It is distinguished from Caroli disease (simple type), which involves bile duct dilatation alone without hepatic fibrosis. Caroli syndrome primarily affects the hepatobiliary system and is associated with the ductal plate malformation, a developmental abnormality of the intrahepatic bile ducts. It is most commonly linked to autosomal rec

How is Caroli syndrome inherited?

Caroli syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Caroli syndrome?

15 specialists and care centers treating Caroli syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.